Company Novo Biomedics S.r.l. with Fiscal Code 26839678
recorded a turnover of 2024 of
518.546,
with a net profit of
111.297
and having an average number of employees of
3.
The company operates in the field of CAEN Ver.3: Intermedieri în comerţul cu amănuntul nespecializat; CAEN Ver.2: Comert cu amanuntul prin intermediul caselor de comenzi sau prin Internet; having the NACE code 4791.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Novo Biomedics S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
502.216
572.028
455.401
524.165
590.892
646.633
529.903
296.404
431.443
518.546
Total Income - EUR
504.338
572.846
471.601
527.661
596.922
655.264
552.364
306.142
441.202
518.736
Total Expenses - EUR
554.518
574.246
458.197
496.371
508.228
540.669
435.803
271.968
304.878
384.685
Gross Profit/Loss - EUR
-50.180
-1.400
13.404
31.290
88.694
114.595
116.562
34.175
136.324
134.051
Net Profit/Loss - EUR
-50.180
-1.400
8.861
26.048
83.055
108.907
112.816
32.027
132.116
111.297
Employees
8
10
10
10
9
6
6
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 20.9%, from 431.443 euro in the year 2023, to 518.546 euro in 2024.
The Net Profit decreased by -20.081 euro, from 132.116 euro in 2023, to 111.297 in the last year.
Check the financial reports for the company - Novo Biomedics S.r.l.
Financial Rating - NOVO BIOMEDICS S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Novo Biomedics S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Novo Biomedics S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Novo Biomedics S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novo Biomedics S.r.l. - CUI 26839678
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
69.220
61.953
83.260
65.986
92.525
87.674
77.745
66.974
59.103
503.240
Current Assets
218.436
208.521
178.418
214.246
330.402
249.215
319.340
272.112
290.309
313.350
Inventories
173.748
173.559
158.917
176.694
171.343
130.440
140.133
113.740
121.012
131.306
Receivables
29.646
26.921
17.585
27.472
102.365
17.657
47.641
78.760
142.348
73.469
Cash
15.043
8.042
1.916
10.080
56.694
101.118
131.565
79.612
26.949
108.575
Shareholders Funds
-47.319
-48.236
-38.559
-11.804
71.436
178.989
287.836
322.018
313.842
306.299
Social Capital
225
223
219
215
211
207
202
203
202
201
Debts
382.775
366.127
347.335
350.953
408.711
155.962
109.060
17.068
45.089
510.579
Income in Advance
153
151
9.440
6.850
4.346
1.938
189
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4791 - 4791"
CAEN Financial Year
4799
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
313.350 euro in 2024 which includes Inventories of
131.306 euro, Receivables of
73.469 euro and cash availability of
108.575 euro.
The company's Equity was valued at
306.299 euro, while total Liabilities amounted to
510.579 euro.
Equity decreased by -5.789 euro, from 313.842 euro in 2023, to 306.299 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novo Biomedics S.r.l.